Delivery Order 36C26323D0001-36C26323N1092
- Not listed
- This is a federal contract award to Biodesix, Inc., a for-profit medical laboratory and diagnostic testing company based in Colorado. The contract, valued at $11,434.24, is a Delivery Order with a Firm Fixed Price awarded by the U.S. Department of Veterans Affairs (VA) for LUNG BLOOD TEST OPTION 1 services. The contract has an ultimate completion date of December 31, 2024 and was awarded on January 1, 2024. Biodesix has been awarded multiple contracts by the VA for its specialized lung blood...
- This federal contract was awarded by the U.S. Department of Veterans Affairs (VA) to Biodesix, Inc., a for-profit medical laboratory and diagnostic testing company. The contract, valued at $61,043.55, is for the provision of lung testing services to the VA. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of August 14, 2024. Biodesix, the prime contractor, has been awarded multiple VA contracts for specialized lung blood testing services,...
- The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call contract to Biodesix, Inc., a for-profit medical laboratory and diagnostic testing company based in Boulder, Colorado. The $390,678.72 firm fixed-price contract is for STX Nodify lung cancer screening services, with a period of performance ending on September 30, 2026. Biodesix has been awarded multiple delivery order contracts by various VA regional networks for its specialized lung cancer detection...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price delivery order contract to Biodesix, Inc., a for-profit lung disease diagnostic company based in Boulder, Colorado. The $26,758.29 contract is for the provision of lung blood testing services to support healthcare programs for veterans across multiple states, including Puerto Rico. Biodesix has provided these testing services through numerous delivery order contracts with the VA VHA and its...
- The U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 23 (VISN 23), awarded a delivery order valued at $2,600 to Biodesix, Inc. on October 1, 2024, for Nodify lung blood testing services. This firm fixed-price delivery order supports the VA's healthcare initiatives by providing specialized diagnostic testing capabilities to veteran patients at VA medical centers within the Minneapolis, Minnesota region. The award was issued without a set-aside designation and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $101,143.35 firm fixed price delivery order contract to Biodesix, Inc. of Boulder, Colorado. The contract is for a lung blood test with no set-aside designation. The delivery order was awarded on January 12, 2022 and is to be completed by December 31, 2022. The funding agency is the Veterans Health Administration, which provides healthcare services to eligible military veterans at VA...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a firm fixed-price Blanket Purchase Agreement (BPA) call to Biodesix, Inc. for STX lung cancer screening services, effective October 1, 2024. The contract, valued at $110,906.41 with an ultimate completion date of September 30, 2025, will be performed in Boulder, Colorado. This award carries no set-aside designation and represents a delivery order against Biodesix's existing $2.25 million single-award BPA for STX...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $5,000 firm fixed price delivery order to Biodesix, Inc. for laboratory testing services under its FY23 task order contract vehicle. The period of performance is from October 1, 2022 through September 30, 2023. The delivery order was awarded without a set-aside designation to support the agency's medical and healthcare programs. Biodesix will provide nodify lab testing at its...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 10. The $87,232.50 firm-fixed-price delivery order contract is for the provision of specialized diagnostic testing panels, reagents, and associated services. The contract has an ultimate completion date of January 16, 2024 and was awarded on November 30, 2021. Biofire Diagnostics is an experienced federal...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a firm fixed-price purchase order valued at $116,829.71 to Biocartis US Inc. for cancer marker testing services utilizing the company's Idylla molecular diagnostic platform. The contract, posted as a special notice on March 1, 2022, and awarded on May 16, 2022, requires performance through May 15, 2027, at the contractor's facility in Jersey City, New Jersey. This award was issued through full and open...
- 36C26323D0001Indefinite Delivery Contract
- 36C26323D0001-36C26323N1092Delivery Order
This federal contract award to Biodesix, Inc., a for-profit medical laboratory and diagnostic testing company, was issued by the U.S. Department of Veterans Affairs (VA) to provide Nodify lung blood testing services. The $2,500 firm fixed-price delivery order contract has a completion date of September 30, 2024, and is not set aside for any special designation. Biodesix has been awarded multiple VA contracts for specialized lung testing services, including Nodify lung blood testing, STX lung cancer screening, and other diagnostic testing options, across various Veterans Integrated Service Networks (VISNs). The company holds several significant Indefinite Delivery Vehicles (IDVs) with the VA, including a $20.3 million multiple-award Federal Supply Schedule contract, a $2.25 million Blanket Purchase Agreement for STX Nodify lung cancer screening services, and two single-award Indefinite Delivery Contracts totaling $700,000 and $216,735. These IDVs enable VA medical centers to issue task orders for Biodesix's lung testing capabilities, demonstrating the company's strategic approach to supporting veteran healthcare through innovative diagnostic technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($9k) | 4/30/25 | |
| P00001 | Supplemental Agreement for work within scope | ($9k) | 4/18/24 | |
| Not listed | Not listed | $20.8k | 9/8/23 |